(Q35779384)

10 August 2017

1 reference

title

Vaccination with T cell-defined antigens (English)

1 reference

10 August 2017

8

Francesco M Marincola

1 reference

10 August 2017

Monica C Panelli

1

1 reference

10 August 2017

Ena Wang

2

1 reference

10 August 2017

Vladia Monsurrò

3

1 reference

10 August 2017

Ping Jin

4

1 reference

10 August 2017

Katia Zavaglia

5

1 reference

10 August 2017

Kina Smith

6

1 reference

10 August 2017

Yvonne Ngalame

7

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

Expert Opinion on Biological Therapy

10 August 2017

published in

1 reference

10 August 2017

volume

4

1 reference

10 August 2017

issue

5

1 reference

10 August 2017

page(s)

697-707

1 reference

Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going?

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

Tumors as elusive targets of T-cell-based active immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

Peptide vaccine trials for melanoma: preclinical background and clinical results

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

Evaluation of melanoma vaccines with molecularly defined antigens by ex vivo monitoring of tumor-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

Antigen-based immunotherapy of melanoma: Canvaxin therapeutic polyvalent cancer vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

Results of clinical trials with an allogenic melanoma tumor cell lysate vaccine: Melacine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

Dynamic changes of specific T cell responses to melanoma correlate with IL-2 administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

Local delivery of poxvirus vaccines for melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

Active-specific immunization against melanoma: is the problem at the receiving end?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

Dendritic cells as vectors for immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

Rational peptide-based tumour vaccine development and T cell monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

Immune surveillance against a solid tumor fails because of immunological ignorance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

Cancer immunoediting: from immunosurveillance to tumor escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

Natural selection of tumor variants in the generation of "tumor escape" phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

Translational Medicine: A two-way road

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

Tumor antigens recognized by T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

Cancer vaccines based on the identification of genes encoding cancer regression antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

New paths in human cancer serology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

Phase 2 trial of vaccination with tyrosinase peptides and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

Three new DPB1 alleles identified in a Bantu-speaking population from central Cameroon

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

Molecular and functional profiling of memory CD8 T cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

Lineage relationship and protective immunity of memory CD8 T cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

Selective changes in expression of HLA class I polymorphic determinants in human solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

Antigen-processing machinery breakdown and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

Intensity of the vaccine-elicited immune response determines tumor clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

The activatory receptor 2B4 is expressed in vivo by human CD8+ effector alpha beta T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

Status of activation of circulating vaccine-elicited CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

Skewed maturation of memory HIV-specific CD8 T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

Functional heterogeneity of vaccine-induced CD8(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

Failing immune control as a result of impaired CD8+ T-cell maturation: CD27 might provide a clue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

Tumor antigens recognized by T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

A natural history of melanoma: serial gene expression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

HLA associations in the antitumor response against malignant melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

Gene polymorphisms, inflammatory diseases and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

A strategy for detection of known and unknown SNP using a minimum number of oligonucleotides applicable in the clinical settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

Molecular classification of cutaneous malignant melanoma by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

Genetic instabilities in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

21 January 2018

The dual role of IL-10.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

Transcription factors IRF-1 and IRF-2: linking the immune responses and tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

Immune Enhancement of Skin Carcinogenesis by CD4+ T Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.5.697

21 January 2018

Identifiers

DOI

10.1517/14712598.4.5.697

1 reference

10 August 2017

1 reference